FDA-Drug2022-11-23Class III
Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.
Aadi Bioscience
Hazard
Failed Stability Specifications
Sold states
Within the U.S Market - PA, AL, KY, TN
Affected count
2,333 vials
Manufactured in
17383 W Sunset Blvd Ste A250, N/A, Pacific Palisades, CA, United States
Products
Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0059-2023Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief